The clinical application potential of extracellular matrix in cardiac tissue engineering.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

4 citing papers in PubMed.

1. Extracellular Matrix Tissue Patch for Aortic Arch Repair in Pediatric Cardiac Surgery: A Single-Center Experience.Journal of clinical medicine · 2025
   Article
2. Biological Scaffolds for Congenital Heart Disease.Bioengineering (Basel, Switzerland) · 2023
   Review
3. Promoting Cardiac Regeneration and Repair Using Acellular Biomaterials.Frontiers in bioengineering and biotechnology · 2020
   Review
4. The extracellular matrix patch implanted in the right ventricle evaluated with cardiovascular magnetic resonance protocol to assess regional physio-mechanical properties.Interactive cardiovascular and thoracic surgery · 2017
   Article

Corrections and comments

• Comment on
  In situ constructive myocardial remodeling of extracellular matrix patch enhanced with controlled growth factor release.2015

Authors and funding

2 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as